← Back to Search

VR Assessment for Retinal Disease

Phase 1
Recruiting
Led By Brett G Jeffrey, Ph.D.
Research Sponsored by National Eye Institute (NEI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant must be five years of age or older
Participant must be able to cooperate with the testing required for this study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up variable
Awards & highlights

Study Summary

This trial is testing a virtual reality tool to see if it can help assess mobility in people with retinal disease. Eligible participants are those aged 5 and older with retinal disease that affects their vision, and healthy volunteers. The VR tool will be used to navigate through 4 obstacle courses presented in VR.

Who is the study for?
This trial is for people aged 5 and older with retinal diseases that affect vision, such as Cone-Rod Dystrophy or Retinitis Pigmentosa. Healthy volunteers without retinal disease can also join. Participants must be able to follow the study's procedures and those under legal age need consent from a guardian.Check my eligibility
What is being tested?
The study is testing a new Virtual Reality (VR) tool designed to assess how well people with retinal disease can move through virtual obstacle courses. The goal is to see if this VR tool can accurately track changes in their mobility over time.See study design
What are the potential side effects?
Since the intervention involves non-invasive VR technology, side effects are minimal but may include eye strain, temporary visual disturbances, or discomfort from wearing goggles during the assessment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least five years old.
Select...
I can follow the testing procedures required for this study.
Select...
I do not have any eye diseases.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~variable
This trial's timeline: 3 weeks for screening, Varies for treatment, and variable for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Effect of prior game play
Feasibility of the tool
VR mobility test parameters

Trial Design

1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
Participants with retinal disease, healthy volunteers

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Eye Institute (NEI)Lead Sponsor
546 Previous Clinical Trials
1,401,829 Total Patients Enrolled
24 Trials studying Retinitis Pigmentosa
14,371 Patients Enrolled for Retinitis Pigmentosa
Brett G Jeffrey, Ph.D.Principal InvestigatorNational Eye Institute (NEI)
4 Previous Clinical Trials
600 Total Patients Enrolled
1 Trials studying Retinitis Pigmentosa
370 Patients Enrolled for Retinitis Pigmentosa

Media Library

VR Motility Tool Clinical Trial Eligibility Overview. Trial Name: NCT04289571 — Phase 1
Retinitis Pigmentosa Research Study Groups: Participants
Retinitis Pigmentosa Clinical Trial 2023: VR Motility Tool Highlights & Side Effects. Trial Name: NCT04289571 — Phase 1
VR Motility Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT04289571 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA given its stamp of approval to the VR Motility Tool?

"The potential safety of the VR Motility Tool was assigned a score of 1, as it is currently being assessed in Phase 1 clinical trials without ample evidence for both its efficacy and security."

Answered by AI

What is the current enrollment size of this experiment?

"Affirmative. The information on clinicaltrials.gov reports that this study is currently recruiting suitable participants, first posted on December 5th 2022 and most recently modified November 29th 2022. In total, 165 volunteers are needed from a single site location."

Answered by AI

Are there presently any openings for this clinical experiment?

"Affirmative. Data published on clinicaltrials.gov corroborates that this experiment, which was first announced on December 5th 2022, is actively looking for participants. A total of 165 patients are needed from a single centre."

Answered by AI
~110 spots leftby Dec 2030